金色化物Rg5通过细胞循环途径抑制HeLa细胞的增殖
Qianwen Mi1, Hang Sun1, Heyu Wang1
1College of Food Science and Engineering, Jilin Agricultural University, Changchun, 130118 China.
Food science and biotechnology
|April 8, 2025
概括
银化物Rg5显著降低了细胞周期中的关键蛋白质,包括宫癌细胞中的小染色体维护复杂组件6 (MCM6). 这表明MCM6是治疗宫癌的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 宫癌仍然是全球女性癌症死亡的主要原因.
- 人类癌细胞生长中的金色化物Rg5的作用是公认的,但其精确的作用机制尚不清楚.
- 了解受金色化物Rg5影响的分子通路对于开发向疗法至关重要.
研究的目的:
- 在宫癌中研究金色化物Rg5的初步机制.
- 分析金氏酸Rg5对HeLa宫癌细胞中的基因表达的影响.
- 为了识别Ginsenoside Rg5介导的宫癌治疗的潜在分子标.
主要方法:
- 治疗HeLa细胞的使用Ginsenoside Rg5.5.
- 定量逆转录聚合酶链反应 (RT-qPCR) 来评估基因表达.
- 西方血栓测试用于评估蛋白质水平.
- RNA测序 (RNA-seq) 用于全面的基因表达造型.
主要成果:
- 在RT-qPCR,西部斑点和RNA-seq分析中观察到细胞循环途径蛋白的持续下调.
- 迷你染色体维护复杂组件6 (MCM6),循环A2 (CCNA2),循环依赖激酶6 (CDK6) 和细胞分裂周期6 (CDC6) 的表达在治疗的HeLa细胞中显著降低.
- 迷你染色体维护复杂组件6 (MCM6) 显示了最实质性的抑制作用.
结论:
- 金色化物Rg5治疗导致子宫癌细胞中关键细胞循环调节者的表达显著下降.
- 降低MCM6,CCNA2,CDK6和CDC6的调节表明,金赛诺Rg5会干扰细胞循环的进展.
- MCM6成为一种非常有前途的分子标,用于开发新的宫癌治疗方法.
相关概念视频
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:23Negative Regulator Molecules
35.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.0K
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
01:24Small GTPases - Ras and Rho
3.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.8K
01:45Positive Regulator Molecules
105.6K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.6K
02:38The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K